Cargando…
Effectiveness of Convalescent Plasma Therapy for COVID-19 Patients in Hunan, China
OBJECTIVE: To investigate clinical efficacy and safety of convalescent plasma (CP) therapy in coronavirus disease 2019 (COVID-19) patients. METHODS: We included 4 severe patients and 3 critical patients. The date of admission to hospital ranged from January 30 to February 19, 2020. We retrospectivel...
Autores principales: | Hu, Xingsheng, Hu, Chunhong, Jiang, Dixuan, Zuo, Qian, Li, Ya, Wang, Yang, Chen, Xiangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745599/ https://www.ncbi.nlm.nih.gov/pubmed/33402882 http://dx.doi.org/10.1177/1559325820979921 |
Ejemplares similares
-
Finding the Best Antiviral Regimen for COVID-19: A Double-Center
Retrospective Cohort Study of 207 Cases in Hunan, China
por: Hu, Xingsheng, et al.
Publicado: (2020) -
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China
por: Hu, Xingsheng, et al.
Publicado: (2020) -
Epidemiological and clinical features of 201 COVID-19 patients in Changsha city, Hunan, China
por: Zhou, Jian, et al.
Publicado: (2020) -
Use of convalescent plasma in COVID-19 patients in China
por: Zhu, M., et al.
Publicado: (2020) -
Challenges of Convalescent Plasma Therapy on COVID-19
por: Zhao, Qian, et al.
Publicado: (2020)